Therefore, SNPs of these loci were selected for examination in this case–control study with the aim of unmasking the regulatory mechanisms IL-17 and NF-κB1 production and providing a genetic marker to predict ARDS risk and development. This evidence concerns the gene IL17A and acute respiratory distress syndrome.